Zuckermann, M., He, C., Andrews, J., Bagchi, A., Sloan-Henry, R., Bianski, B., . . . Baker, S. J. (2024). Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy. Molecular cancer, 23(1), 123-19. https://doi.org/10.1186/s12943-024-02027-6
Chicago-Zitierstil (17. Ausg.)Zuckermann, Marc, et al. "Capmatinib Is an Effective Treatment for MET-fusion Driven Pediatric High-grade Glioma and Synergizes with Radiotherapy." Molecular Cancer 23, no. 1 (2024): 123-19. https://doi.org/10.1186/s12943-024-02027-6.
MLA-Zitierstil (9. Ausg.)Zuckermann, Marc, et al. "Capmatinib Is an Effective Treatment for MET-fusion Driven Pediatric High-grade Glioma and Synergizes with Radiotherapy." Molecular Cancer, vol. 23, no. 1, 2024, pp. 123-19, https://doi.org/10.1186/s12943-024-02027-6.